Mark Lingen to Mouth Neoplasms
This is a "connection" page, showing publications Mark Lingen has written about Mouth Neoplasms.
Connection Strength
8.438
-
Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Oral Cavity Dysplasia: Why Does Histologic Grading Continue to be Contentious? Head Neck Pathol. 2023 Jun; 17(2):292-298.
Score: 0.696
-
The promise and potential peril of at-home oral cancer testing. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023 01; 135(1):1-2.
Score: 0.671
-
Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association. J Am Dent Assoc. 2017 11; 148(11):797-813.e52.
Score: 0.474
-
Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: A report of the American Dental Association. J Am Dent Assoc. 2017 10; 148(10):712-727.e10.
Score: 0.471
-
Validation of LOH profiles for assessing oral cancer risk. Cancer Prev Res (Phila). 2012 Sep; 5(9):1075-7.
Score: 0.331
-
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013 Jan; 49(1):1-8.
Score: 0.329
-
Genetics/epigenetics of oral premalignancy: current status and future research. Oral Dis. 2011 Apr; 17 Suppl 1:7-22.
Score: 0.300
-
Screening for oral premalignancy and cancer: what platform and which biomarkers? Cancer Prev Res (Phila). 2010 Sep; 3(9):1056-9.
Score: 0.288
-
Pragmatics versus contrarians: how does one resolve their differences with respect to oral cancer screening? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Mar; 109(3):325-6.
Score: 0.279
-
ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis. Cancer Prev Res (Phila). 2009 Apr; 2(4):385-93.
Score: 0.261
-
Direct-to-consumer advertising for oral cancer screening devices. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Mar; 107(3):299-300.
Score: 0.258
-
Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008 Jan; 44(1):10-22.
Score: 0.234
-
Improving translational research for oral cancer screening aids: putting my "money" where my mouth is. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Sep; 104(3):301-2.
Score: 0.234
-
Oral cancer screening aids: where is the science? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Feb; 103(2):153-4.
Score: 0.225
-
Multistate oral carcinogenesis-A prospective cohort study and a parallel case-control study in Taiwan. Oral Oncol. 2025 Mar; 162:107210.
Score: 0.196
-
Classification and identification of genes associated with oral cancer based on gene expression profiles. A preliminary study. N Y State Dent J. 2003 Feb; 69(2):23-6.
Score: 0.171
-
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer. Nat Commun. 2022 08 17; 13(1):4829.
Score: 0.165
-
Angiogenesis in oral cancer. J Dent Educ. 2001 Nov; 65(11):1282-90.
Score: 0.156
-
Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma. Cell Rep Med. 2021 09 21; 2(9):100399.
Score: 0.155
-
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2021 07 20; 7:CD010276.
Score: 0.153
-
Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma. Cancer. 2021 05 15; 127(10):1576-1589.
Score: 0.147
-
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study. J Natl Cancer Inst. 2020 10 01; 112(10):1047-1054.
Score: 0.145
-
Response to Brandt, Bednarz-Knoll, Kleinheinz et al. J Natl Cancer Inst. 2020 09 01; 112(9):970-971.
Score: 0.144
-
Society of Behavioral Medicine position statement: Society of Behavioral Medicine supports oral cancer early detection by all healthcare providers. Transl Behav Med. 2019 07 16; 9(4):819-822.
Score: 0.133
-
Understanding the biology of oral cancer and chemoprevention. CDS Rev. 1998 May-Jun; 91(4):24-8.
Score: 0.123
-
Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 06; 125(6):650-669.
Score: 0.122
-
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. J Natl Cancer Inst. 2018 03 01; 110(3).
Score: 0.121
-
Screening for oral cancer-a perspective from the Global Oral Cancer Forum. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jun; 123(6):680-687.
Score: 0.109
-
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
Score: 0.105
-
Myofibromas of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Sep; 80(3):297-302.
Score: 0.102
-
Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery. Oral Oncol. 2015 Nov; 51(11):1011-1019.
Score: 0.102
-
Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis. Cancer Res. 2015 Sep 15; 75(18):3958-3969.
Score: 0.102
-
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2015 May 29; (5):CD010276.
Score: 0.100
-
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors. PLoS One. 2014; 9(3):e90171.
Score: 0.092
-
Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2013 Nov 21; (11):CD010173.
Score: 0.090
-
Immunoprofiling of oral squamous cell carcinomas reveals high p63 and survivin expression. Oral Dis. 2014 Apr; 20(3):e76-80.
Score: 0.087
-
Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. Oral Oncol. 2013 Jun; 49(6):525-33.
Score: 0.086
-
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Tex Dent J. 2012 May; 129(5):491-507.
Score: 0.081
-
Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):664-72.
Score: 0.080
-
Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. Cancer Prev Res (Phila). 2011 Feb; 4(2):230-7.
Score: 0.074
-
Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis. Cancer Prev Res (Phila). 2010 Nov; 3(11):1493-502.
Score: 0.073
-
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010 May; 141(5):509-20.
Score: 0.070
-
Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium. Oral Oncol. 2004 Nov; 40(10):1040-7.
Score: 0.048
-
Gene expression levels in different stages of progression in oral squamous cell carcinoma. Proc AMIA Symp. 2002; 415-9.
Score: 0.040
-
Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res. 2006 Jun 15; 66(12):6296-303.
Score: 0.013